Advisory Alpha’s Bausch Health BHC Stock Holding History

Advisory Alpha’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-200	Closed	-$3K	–	162
2020 Q3	$3K	Buy	+200	New	+$3.44K	﹤0.01%	566

Other funds holding BHC

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.63B AUM 5.11% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

PIP

Permian Investment Partners Dallas, Texas $911M AUM 0.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Advisory Alpha's BHC Position: Q4 2020 in Review

Advisory Alpha sold out of Bausch Health (BHC) in Q4 2020, closing a stake of 200 shares — an estimated $3K sold.

Advisory Alpha first reported a position in BHC in Q3 2020 and held it in 1 quarter. The position peaked at $3K in Q3 2020. 339 funds tracked by Wall St. Rank hold BHC as of Q4 2020.

Advisory Alpha reported no remaining Bausch Health position as of Q4 2020 after selling out during the quarter.
Advisory Alpha sold 200 Bausch Health shares in Q4 2020, an estimated $3K.
Advisory Alpha first reported a position in Bausch Health in Q3 2020 and held it in 1 quarter.
Advisory Alpha's Bausch Health position peaked at $3K in Q3 2020.
339 funds tracked by Wall St. Rank held Bausch Health as of Q4 2020.

Based on Advisory Alpha's 13F filing for Q4 2020, filed 16 Feb 2021.